Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Lowered to $430 at UBS

September 17, 2026 8:28 AM
UBS analyst Michael Yee lowered the price target on Amgen (NASDAQ: AMGN) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change